ADAG
Adagene, Inc.
NASDAQ · Healthcare · Biotechnology · CN
$2.29
+11.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.45x
- Price / sales
- 16.50x
- Price / cash flow
- -7.97x
Enterprise value
- Enterprise value
- $48.5M
- EV / sales
- 5.20x
- EV / EBITDA
- -2.22x
- EV / EBIT
- -2.17x
- Market cap
- $153.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026